Pseudophakia Clinical Trial
— MERoVOfficial title:
Monofocal Extended Range of Vision (MERoV) Study
NCT number | NCT04011696 |
Other study ID # | 264296 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 3, 2019 |
Est. completion date | May 31, 2022 |
Verified date | November 2023 |
Source | Brighton and Sussex University Hospitals NHS Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The investigators are proposing this research project to: 1. Screen a set of patients after normal cataract surgery with a single focus lens aimed at good distance vision at 3 months after surgery to identify patients who are able to see and read well without glasses. 2. Identify the combination of factors responsible for this phenomenon in the patients who are achieving this. Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery. At 3 months after surgery they will have their un-corrected vision checked. They will also have their reading speed assessed without any glasses. They will undergo a through refractive check by an optometrist to assess the power of the spectacles (if needed) and following this they will have a scan of the eye (a technique known as wave front analysis which uses very sophisticated optics) to capture the optical distortions in the structures of the eye. If this study is able identify factor/s responsible for giving good unaided reading and distance vision then this factor can be reproduced in eyes undergoing cataract surgery. This will mean that the patients can have an increased option of spectacle independence without the need for expensive multifocal IOLs and their associated side effects such as glare and halos, particularly at night.
Status | Completed |
Enrollment | 412 |
Est. completion date | May 31, 2022 |
Est. primary completion date | May 31, 2022 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Uneventful cataract surgery, sequential recruitment, potential to see 20/40 (6/12) unaided or better postoperatively, no significant macular pathology and willing to follow up at 3 months. Exclusion Criteria: - Any ocular co-morbidity, which will preclude an expected postoperative 20/40 (6/12) unaided, distance vision. (e.g. amblyopia, corneal pathology, age related macular degeneration, glaucoma, diabetic retinopathy, other previous ocular surgeries), posterior capsule opacification,inability to read English text or physically or mentally unable to and cooperate with the postoperative assessment |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Mayank Nanavaty | Brighton |
Lead Sponsor | Collaborator |
---|---|
Brighton and Sussex University Hospitals NHS Trust | European Society of Cataract and Refractive Surgeons, King's College London |
United Kingdom,
Nanavaty MA, Spalton DJ, Boyce J, Saha S, Marshall J. Wavefront aberrations, depth of focus, and contrast sensitivity with aspheric and spherical intraocular lenses: fellow-eye study. J Cataract Refract Surg. 2009 Apr;35(4):663-71. doi: 10.1016/j.jcrs.2008.12.011. — View Citation
Nanavaty MA, Spalton DJ, Marshall J. Effect of intraocular lens asphericity on vertical coma aberration. J Cataract Refract Surg. 2010 Feb;36(2):215-21. doi: 10.1016/j.jcrs.2009.08.024. — View Citation
Nanavaty MA, Vasavada AR, Patel AS, Raj SM, Desai TH. Analysis of patients with good uncorrected distance and near vision after monofocal intraocular lens implantation. J Cataract Refract Surg. 2006 Jul;32(7):1091-7. doi: 10.1016/j.jcrs.2006.03.021. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Uncorrected distance and near vision | Uncorrected distance of 20/40 and near of J4 | 3 months postoperatively | |
Secondary | Spherical error | Spherical error on manifest refraction | 3 months postoperatively | |
Secondary | astigmatic error | astigmatic error on manifest refraction | 3 months postoperatively | |
Secondary | Pupil size | Pupil size in mesopic condition | 3 months postoperatively | |
Secondary | Total spherical and vertical coma aberrations | Total spherical and vertical coma aberrations on aberrometry | 3 months postoperatively | |
Secondary | Reading speed and critical font size | Measured on Salzburg's reading desk | 3 months postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01193504 -
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
|
Phase 4 | |
Completed |
NCT00347243 -
Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses
|
Phase 4 | |
Completed |
NCT04208633 -
Correlation Between Sulcus Anatomy and Other Parameters After Horizontal & Vertical Intraocular Lens (IOLs) Placements
|
N/A | |
Recruiting |
NCT06041139 -
Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
|
||
Completed |
NCT04533191 -
Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)
|
||
Completed |
NCT05735990 -
Retrospective Clinical Investigation of the Safety and Performance of 640PM Trifocal IOL Implantation in Patients With Cataract and/or Ametropia (Hyperopia, Myopia) and/or Presbyopia
|
||
Recruiting |
NCT04175951 -
Tecnis Eyhance Versus Rayner RayOne Study
|
N/A | |
Not yet recruiting |
NCT06056154 -
Safety and Efficacy of the Hydrophobic Intraocular Lens AsqelioTM Monofocal With Biaspheric Design
|
||
Not yet recruiting |
NCT05531110 -
Comparison of Two Aspheric Intraocular Lenses for Micro-monovision
|
N/A | |
Completed |
NCT01004549 -
An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular Lenses
|
N/A | |
Recruiting |
NCT03823092 -
Polarization Perception in Health and Disease. Testing a New Sight Test
|
||
Completed |
NCT05226884 -
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
|
||
Completed |
NCT01310127 -
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
|
Phase 4 | |
Completed |
NCT05335408 -
Evaluation of Visual Function After Bilateral Implantation of EDOF IOLs
|
N/A | |
Completed |
NCT05611073 -
Maximizing Visual Outcomes With Eyhance IOLs
|
||
Completed |
NCT04319497 -
Subjective and Objective Refraction in Pseudophakic Patients
|
N/A | |
Completed |
NCT05418153 -
Synergy Lens Outcomes Evaluation
|
||
Recruiting |
NCT06065072 -
Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900
|
||
Completed |
NCT02450799 -
Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation
|
N/A | |
Completed |
NCT00428363 -
Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification
|
Phase 4 |